Anavex Life Sciences Corp (AVXL)

[polarbear77]

Reasonable questions that I've not the answers to; however IF he had bad news or negative developments that he wasn't expecting:

a) wouldn't the quarterly report on Monday (or combined with some form of disclosure) have contained such news? If he had negative material information on Monday, why exclude it from the quarterly report and the "corporate highlights" and "planned objectives" sections???

b) why would you highlight and backslap about having already designed the 3 trials to move forward this year; AND make a point of how innovative the trials will be by saying point blank: "To our knowledge, this is the first use of this approach in the design of clinical trials...."

Your questions are valid, but I'm personally not willing/able to make that conclusion yet.


But I'm long and biased and not a scientist.


“We look forward to initiating these placebo-controlled clinical trials. The respective trial designs are based on broad genomic and biomarker characterization, pharmacokinetic and pharmacodynamic modeling including data from patients in previous ANAVEX™ 2-73 trials, as well as preclinical translational science. To our knowledge, this is the first use of this approach in the design of clinical trials for Alzheimer’s disease, Parkinson’s disease and Rett syndrome, and marks a shift towards advancing implementation of precision medicine for these and other neurodegenerative and neurodevelopmental diseases.”